Eltrombopag Improves Outcomes in Kids With Newly Diagnosed ITP

(MedPage Today) -- SAN DIEGO -- Treatment with eltrombopag (Promacta) for pediatric patients with newly diagnosed immune thrombocytopenia (ITP) led to a significantly higher rate of durable platelet response compared with standard first-line...